While vaccines can provide protection against COVID-19 and even prevent severe illness, for certain populations – including those with immunodeficiencies – vaccines might not be enough.
Meridian is currently enrolling people with compromised immune systems for a study of an investigational COVID-19 prophylactic (prevention) medication.
- Must be ages 18 and older
- Must be moderate to severely immunocompromised: Must have a medical condition or be receiving treatments that may result in an immune compromise or an inadequate immune response to COVID-19 vaccination, including but not limited to malignant cancer treatments, organ transplant immunosuppressive therapy, stem cell transplant, moderate or severe primary immunodeficiency, and advanced or untreated HIV infection
- Will receive compensation for study-related time
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you or your child.
You can also talk to a Meridian enrollment specialist about this study by calling (912) 623-2240.
Submit your information
Meridian Clinical Research
415 Hooper Road
Endwell, NY 13760
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.